Navigation Links
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Date:7/30/2009

SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans to develop a DNA-based orthobiologics product portfolio based on research and development by Cardium's Tissue Repair Company that will initially focus on non-union bone fractures for medically-compromised patients, and spinal fusion for patients with degenerative disc disease. Orthobiologics is a rapidly growing segment of the orthopedics market and represents biologically-active products designed to enhance musculo-skeletal repair and regeneration.

(Photo:http://www.newscom.com/cgi-bin/prnh/20090730/LA54252)

(Logo:http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

Following on results observed with Tissue Repair's Excellarate(TM) product candidate, which is targeted to the repair of soft tissues (particularly diabetic ulcers), the Company's orthobiologics initiative will build on and extend the underlying technology that has been developed by the Tissue Repair Company to hard tissue applications such as bone, including: (1) proprietary Gene Activated Matrix(TM) or GAM(TM) delivery and ligand targeting; (2) use of GAM to locally produce proteins capable of stimulating bone and other tissue growth; and (3) a substantial body of pre-clinical research and development supporting the use of GAM to deliver bone growth factors. Cardium believes that future DNA-based products offer the potential to provide patients and healthcare systems with more cost-effective alternatives to current and planned protein-based therapeutics.

Cardium's initial orthobiologics focus will be on the development of Osteorate
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
2. Cardium Regains Listing Compliance with NYSE Amex
3. Cardiums InnerCool Therapies Business to Be Acquired By Royal Philips Electronics
4. Cardium Announces Conference Call and Webcast to Review Recent Developments and Future Plans for the Excellarate(TM) Clinical Development Program
5. FDA has Granted HUD (Humanitarian Use Device) Designation to ITGIs Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts
6. Cardium Completes $3.5 Million Credit Facility
7. Cardium Announces Retirement of Director
8. Cardiums InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
9. Cardiums InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
10. Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units
11. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... June 30, 2015 , ... This cutting edge standard making ... Featuring 12 distinct peaks, the WAV-8 is the world’s first cuvette-shaped, solid-state filter ... deep into the NIR range. Previous spectrophotometer calibration standards, such as those made from ...
(Date:6/29/2015)... ... June 29, 2015 , ... MediVet Biologics ... of the agreement, MediVet will acquire the rights to a portfolio of cultures, ... in pre-clinical development as a potential next-generation treatment for various musculoskeletal and internal ...
(Date:6/29/2015)... DIEGO , June 29, 2015 BioNano ... group of top research institutes, announced today that a ... Mount Sinai resulted in the creation of the first ... complementary single DNA molecule methods for sequencing and genome ... , provided the comprehensive analysis of the contiguous diploid ...
(Date:6/29/2015)... 29, 2015  MiMedx Group, Inc. (NASDAQ: MDXG ... tissue and patent-protected processes to develop and market advanced ... Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, ... Petit, has been awarded the Lifetime Achievement Award in ... The Entrepreneur Of The Year Program, ...
Breaking Biology Technology:FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 2FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 3MediVet Biologics Acquires Exclusive Patent License from Kansas State University 2MediVet Biologics Acquires Exclusive Patent License from Kansas State University 3BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date 2BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date 3EY Entrepreneur Of The Year Program Recognizes Pete Petit, The Chairman & CEO of MiMedx 2
... Pharma,Inc. (Nasdaq: APPY ) an emerging bio-pharmaceutical ... diagnostics for animals and humans, today,announced that it ... a private placement with a group of existing ... AspenBio will receive,approximately $18 million in gross proceeds ...
... N.J., Dec. 20 Memory,Pharmaceuticals Corp. (Nasdaq: ... in a randomized, double-blind, placebo-controlled Phase 2a clinical,trial ... receptor partial,agonist, in cognitive impairment associated with schizophrenia ... tolerability and cognitive effects,of three doses of MEM ...
... /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC Bulletin Board: CHBT), a ... marketing and,distribution of probiotics dietary supplements, today announced ... Eastern Time on Monday, August 13,2007, to discuss ... June 30, of its 2008 fiscal year. ...
Cached Biology Technology:AspenBio Pharma Announces $18 Million Private Placement of Common Stock 2AspenBio Pharma Announces $18 Million Private Placement of Common Stock 3Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia 2Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia 3Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia 4China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results 2
(Date:6/23/2015)... June 23, 2015   MedNet Solutions , ... the entire spectrum of clinical research, is pleased ... ™ , the company,s intuitive, flexible and affordable ... Silver 2015 Stevie® Award by the American ... Services Website category.  The American Business Awards are ...
(Date:6/23/2015)... PALM BEACH GARDENS, Fla. , June ... of multi-factor identity management and authentication solutions, today ... Altus strong, multi-factor authentication solution.  The ... ease of use of the DigitalPersona Altus ... and biometric reader compatibility. In ...
(Date:6/17/2015)... , Deutschland und GERMANTOWN, Maryland ... Investigator ®   Produktlinie mit DNA-Tests ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... neue STR-Testkits der Produktlinie Investigator ... in den Markt eingeführt. Die neuen Kits zur Erstellung ...
Breaking Biology News(10 mins):MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6
... in the brains of rats to help focus ... sensory pathways to make it easier to block ... found. , Their report in the Journal of ... with attention deficit and hyperactivity disorders to improve ...
... unique nanoparticles that convert laser light into useful information, ... pH meter. , The discovery, which appears online this ... the first potential means of measuring accurate pH changes ... tissue and cells. , "Almost every biologist I speak ...
... PLoS Genetics has published the findings of a team ... Institute that provides a whole genome analysis of the ... as Dictyostelium. , Led by Dr. Janet ... of kinases, which are enzymes involved in cell communication ...
Cached Biology News:Ritalin packs punch by elevating norepinephrine, suppressing nerve signal transmissions 2Ritalin packs punch by elevating norepinephrine, suppressing nerve signal transmissions 3Rice scientists make first nanoscale pH meter 2Scientists elucidate the kinome of key model organism 2
...
Homo sapiens inhibin, beta B (activin AB beta polypeptide) Antigen: Recombinant Protein(142~254aa)...
... Perfuse cells right in your ... The Petri dish Perfusion Chamber has ... outflow that dampen the fluctuations of ... compartment and prevent bubbles from entering ...
... Promega Flipper® Racks are ideal for storage ... tubes. These polypropylene racks withstand extreme temperatures, ... storage. They may also be autoclaved for ... two-sided; one side accommodates 0.5ml microcentrifuge tubes, ...
Biology Products: